Josep Bassaganya-Riera is 10% Owner at Landos Biopharma, Inc. (LABP). They have made 6 open-market trades across 1 company since 2021, most recently 2022-08-05.
CIK 0001843575
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LABP | 500,000 | $11.5M |
Shares reported on the most recent Form 4, priced at the 2022-08-09 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | -13.0% | -28.4% | -71.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LABP | SELL | 2021-12-16 | 2021-12-20 | $4.89 | $738K | -1.6% | -32.8% | -65.2% |
| LABP | SELL | 2021-12-13 | 2021-12-15 | $5.12 | $1.1M | -9.0% | -31.4% | -71.6% |
| LABP | SELL | 2021-12-09 | 2021-12-10 | $5.88 | $601K | -7.0% | -26.9% | -74.9% |
| LABP | SELL | 2021-12-06 | 2021-12-08 | $6.49 | $838K | -26.9% | -35.7% | -77.4% |
| LABP | SELL | 2021-12-01 | 2021-12-03 | $6.61 | $1.1M | -12.7% | -15.3% | -69.2% |
| LABP | SELL | 2021-11-29 | 2021-12-01 | $7.30 | $481K | -20.5% | -28.3% | -69.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.